Arkansas Foundation for Medical Care Teams With Aledade To Arm, Reward Docs

by Gwen Moritz  on Monday, Jul. 14, 2014 12:00 am  

The launch last month of a company called Aledade was national news of note in the health care industry, reported by Bloomberg, Politico, Crain’s Health Pulse, Becker’s Hospital Review, Modern Healthcare and others.

Aledade is what’s called an ACO, an accountable care organization, a relatively new type of entity established by the Patient Protection & Affordable Care Act for the purpose of improving health care quality while controlling unnecessary spending. Aledade’s CEO is Dr. Farzad Mostashari, a fellow of the Brookings Institution in Washington who is best known (if at all) as the man who coordinated the national implementation of electronic medical records for the U.S. Department of Health & Human Services.

Aledade — a play on alidade, the part of an astrolabe navigation tool that points toward the North Star — raised $4.5 million in venture capital on the day it launched in June.

So what does this have to do with Arkansas? Just this:

Mostashari and Aledade have teamed up with the nonprofit Arkansas Foundation for Medical Care to bring their idea for an ACO made up of independent family practitioners to the Natural State as well as Delaware, Maryland and New York City.

The deadline for applying for ACO status is July 31, and Aledade needs to round up 30 to 50 Arkansas primary care docs who have at least 5,000 Medicare patients between them.

“Is it possible to get better health and lower cost?” Mostashari asked during a recent visit to Little Rock. “The way we’ve been paying for health care is part of the problem, and changing the way we pay could be part of the solution.”

Enter Aledade, which, like other ACOs, will share financially in the documented savings that its members achieve for Medicare patients. But unlike most other ACOs — there are two already established in Arkansas — Aledade is looking specifically to enlist primary care physicians who are not affiliated with bigger health care systems and to give them the tools to choose the best and most efficient specialists for Medicare referrals.

Accountable Care

Physicians representing 5.3 million Medicare patients are already participating in ACOs around the country, Mostashari said, and in the first year of operation, 25 percent of those ACOs achieved shared savings for their patients and the Medicare system.

In some cases, he said, the savings was achieved by simply rethinking referrals and approvals that had become almost automatic. But Aledade, with its CEO’s expertise in medical recordkeeping and its partnership with AFMC, is promising its physician members the kind of big-data information that has only recently become available.

Mostashari gives this example: The drug his mother needs for treatment of macular degeneration can range in cost from $400 to $4,000 per dose. Same drug, same dose. The difference, he said, is whether the doctor chooses to use small, expensive single-dose vials of the medication for each Medicare patient or larger, cheaper, multidose vials. Medicare, forbidden by Congress to negotiate pharmaceutical prices, reimburses the ophthalmologist either way.



Please read our comments policy before commenting.